Company patents
CAREGEN CO., LTD.
CAREGEN CO., LTD. demonstrates a strong and sustained focus on Pharmaceutical Preparations, which constitutes 88.5% of its portfolio, and Peptides & Proteins (78.8%), with both categories showing significant growth in 2024 (128.6% and 225.0% YoY, respectively). Surprisingly, despite its core biotech strengths, the company also maintains a substantial patent presence in Cosmetics & Personal Care Use (69.2% of portfolio), indicating a strategic diversification into consumer applications, although patenting in this area, along with others, has seen a decline so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
52 US filings (since 2023) · 5 categories · 7 themes
Development and application of therapeutic proteins or peptides produced through recombinant DNA technology, including fusion proteins and modified growth factors.
Formulations and active ingredients designed to counteract signs of skin aging, such as wrinkles and hyperpigmentation, or to promote skin repair and regeneration through specific biological mechanisms.
Chemical compositions and methods for stimulating hair growth, altering hair structure for styling (e.g., straightening, curling, dyeing), or protecting hair from environmental damage and heat.
Modification of protein or peptide sequences, structures, or post-translational modifications (e.g., glycosylation, lipidation) to enhance their stability, solubility, delivery, or therapeutic efficacy.
Design and engineering of proteins or peptides to directly modulate immune responses, including enhancing antigen presentation, suppressing inflammation, or activating specific immune cell types.
Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.
Design and modification of antibodies or antibody-derived fragments for targeted therapeutic intervention, including bispecific formats, Fc region modifications, and activatable constructs.
Patents
Showing 1-10 of 13
Protein & Peptide Engineering